Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
OXICODONA/NALOXONA RATIOPHARM 5 MG/2,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- OXICODONA HIDROCLORURO — 5 mg
- NALOXONA HIDROCLORURO — 2.5 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- No packs currently marketed
Packs
OXICODONA/NALOXONA RATIOPHARM 5 MG/2,5 MG COMPRIMIDOS DE LIBERACION PROLONGADA EFG 56 comprimidos
56 pcs
National code
Not marketed714653Strength of this pack 5 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 81718Official data
- Marketing authorisation holder
- TEVA PHARMA S.L.U.Official data
- Authorised
- Feb 3, 2017Official data
- Authority form code
- 47Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.